Parainfluenza virus 3 (PIV3) is a respiratory virus associated with severe childhood illnesses, particularly bronchiolitis and pneumonia. It is also known as human parainfluenza virus type 3 (HPIV3). PIV3 is a member of the Paramyxoviridae family, which includes other viruses such as measles, mumps, and respiratory syncytial virus (RSV). Despite its prevalence in the population, there is still much that is unknown about PIV3 and the diseases it causes. In this article, we will discuss the epidemiology, transmission, diagnosis, treatment, and prevention of PIV3.
PIV3 is a common virus, with an estimated 20-40% of all childhood respiratory illnesses being caused by it. It is most commonly seen in young children, with the highest incidence occurring in children between the ages of 6 months and 2 years. PIV3 is more common in the winter months, with peak activity occurring in December and January. It is also more common in certain geographical areas, such as the southeastern United States and in lower-income countries.
PIV3 is spread through contact with respiratory secretions, such as saliva, mucus, or nasal secretions. It is also spread through contact with surfaces or objects that have been contaminated with the virus. PIV3 is highly contagious and can be spread through coughing and sneezing.
The diagnosis of PIV3 is usually made based on clinical symptoms. However, laboratory tests can be used to confirm the diagnosis. These tests include polymerase chain reaction (PCR) tests, virus isolation, and serology tests.
There is no specific treatment for PIV3. Treatment is mainly supportive, and may include oxygen therapy, hydration, and medications to reduce fever and relieve symptoms. In severe cases, hospitalization may be necessary.
The best way to prevent PIV3 is to practice good hygiene. This includes washing hands often with soap and water, avoiding contact with people who are sick, and avoiding sharing items such as cups and utensils. Vaccines are also available to prevent PIV3, but they are not routinely recommended.
Parainfluenza virus 3 is a common virus that is associated with severe childhood illnesses. It is spread through contact with respiratory secretions and contaminated objects. Diagnosis is usually based on clinical symptoms, but laboratory tests can be used to confirm the diagnosis. Treatment is mainly supportive, and prevention is best achieved through good hygiene practices. Vaccines are available, but are not routinely recommended.
1.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
2.
Some triple negative breast cancers might be avoided by longer breastfeeding
3.
Pretreatment Liver Tests Often Overlooked in CDK4/6 Therapy
4.
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
5.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
1.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
2.
Unlocking the Mysteries of the Axillary Vein: Exploring its Role in Human Anatomy
3.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
4.
Optimizing Oncology Practice Revenue: Billing Software, Payer Trends, and Financial Navigation Tools
5.
Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation